FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1074491000202102: Product containing precisely isoniazid 75 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5258863017 Isoniazid 75 mg and rifampicin 150 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
11777511000202118 Product containing precisely isoniazid 75 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
11801711000202114 Isoniazid 75 mg and rifampin 150 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Isoniazid 75 mg and rifampicin 150 mg oral tablet Is a Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) true Inferred relationship Some
Isoniazid 75 mg and rifampicin 150 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Isoniazid 75 mg and rifampicin 150 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Isoniazid 75 mg and rifampicin 150 mg oral tablet Plays role Antitubercular therapeutic role false Inferred relationship Some
Isoniazid 75 mg and rifampicin 150 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Rifampicin true Inferred relationship Some 1
Isoniazid 75 mg and rifampicin 150 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Rifampicin true Inferred relationship Some 1
Isoniazid 75 mg and rifampicin 150 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Isoniazid 75 mg and rifampicin 150 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Isoniazid 75 mg and rifampicin 150 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Isoniazid (substance) true Inferred relationship Some 2
Isoniazid 75 mg and rifampicin 150 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Isoniazid (substance) true Inferred relationship Some 2
Isoniazid 75 mg and rifampicin 150 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Isoniazid 75 mg and rifampicin 150 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 2
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start